Search results
Results from the WOW.Com Content Network
This is a list of investigational antidepressants, or drugs that are currently under development for clinical use in the treatment of depression but are not yet approved. Specific indications include major depressive disorder , treatment-resistant depression , dysthymia , bipolar depression , and postpartum depression , among others.
These are lists of investigational drugs: List of investigational analgesics; List of investigational antidepressants; List of investigational antipsychotics; List of investigational anxiolytics; List of investigational attention deficit hyperactivity disorder drugs; List of investigational autism and pervasive developmental disorder drugs
This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification. Chemical/generic names are listed first, with brand names in parentheses.
Experimental antidepressants (110 P) Experimental anxiolytics (26 P) ... List of investigational social anxiety disorder drugs; ITI-1549; J. JHU-083; JM-1232; JNJ ...
List of investigational antidepressants; List of investigational antipsychotics; List of investigational anxiolytics; List of investigational attention deficit hyperactivity disorder drugs; List of investigational hallucinogens and entactogens; List of investigational obsessive–compulsive disorder drugs; List of investigational sex-hormonal ...
This page was last edited on 3 December 2023, at 22:17 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
List of investigational analgesics; Annual pharmaceutical drug sales; List of anti-vaccination groups; Timeline of antibiotics; List of antidepressants; List of investigational antidepressants; List of investigational antipsychotics; List of antiviral drugs; List of investigational anxiolytics; Doping at the Asian Games
NV-5138 also known as SPN-820 is an investigational new drug that is being evaluated by Navitor Pharmaceuticals and Supernus Pharmaceuticals [2] for the treatment of major depressive disorder (MDD). [3] [1] [4] [5]